As a lecturer in Molecular and Reproductive genetics, I found it frustrating to be lecturing about reproductive health and yet unable to track my own.
My co-founder, Dr Natalie Getreu, an ovarian biologist specialising in fertility preservation, felt the same. We have both dedicated our research careers to women's health yet felt powerless to help women outside of our own laboratories.
We aim to do this by gathering (from a finger prick blood test) biological, biometric and genetic data from healthy, seemingly healthy, and reproductively unhealthy women, learning from each individuals' story and biological footprint. We are bridging the gap between couch and clinic.
Hertility Health asks each woman what she is here for? Is she curious? Is she concerned? Is she trying to conceive? Is she suffering? Depending on her desired outcome, it will be the guiding step along the way, providing clinically relevant results from a home-drawn blood test combined with personalised questions to deliver a report, a plan and a path. Over 30% of women experience gynaecological problems, we are here to help.
Should fertility treatment be the recommended outcome, we will provide a concierge service offering a free initial consultation with a clinic that is trusted and vetted.
Reproductive problems are not prioritised, and women have not been either, which has led to a global drop in fertility rates. We want to stop this drop.
The company is launching Easter 2020, in time to remind women that we need to care about more than just Easter Eggs.
We were fortunate to be accepted to the P4 Precision Medicine Accelerator which shared our goals of making medicine proactive instead of reactive. The people and programme have been instrumental in nurturing our needs from giving support to build our machine learning platform to helping navigate the investor world.
Find out more about Hertility Health.